在心力衰竭中新型试验设计:使用数字健康工具增加实用主义
Adam D DeVore1,2, Marat Fudim3,4, Lars H Lund5,6
1Department of Medicine, Duke University School of Medicine, 200 Trent Drive, 4th Floor, Orange Zone, Room #4225, Durham, NC, 27710, USA. adam.devore@duke.edu.
Current heart failure reports
|December 28, 2023
概括
数字健康工具可以通过增强务实设计来提高心力衰竭临床试验的效率. 这加快了新的心力衰竭治疗方法和实施策略的交付速度.
科学领域:
- 心脏病学 心脏病学
- 临床试验 临床试验
- 数字健康数字健康
背景情况:
- 心力衰竭是一个重大的临床和公共卫生挑战.
- 提高心力衰竭临床试验的效率对于推进疗法至关重要.
- 电子健康 (eHealth) 平台和数字健康工具越来越多地用于心力衰竭护理.
研究的目的:
- 审查利用电子健康和数字健康工具改善心力衰竭临床试验设计的机会.
- 探索这些工具如何减少临床试验的复杂性和提高临床试验的效率.
- 确定加速开发和实施心力衰竭治疗的策略.
主要方法:
- 审查当前的文献和最近的心力衰竭临床试验的例子.
- 分析电子健康和数字健康工具如何与实用临床试验设计原则保持一致 (例如,PRECIS-2工具).
- 检查针对改善的特定临床试验设计领域.
主要成果:
- 电子健康平台和数字健康工具为改善心力衰竭临床试验设计提供了重大机会.
- 结合这些数字工具支持的务实设计元素,可以解决试验复杂性,提高效率.
- 这些工具可以加速为新的心力衰竭治疗方法生成高质量的证据.
结论:
- 电子健康和数字健康工具的整合为优化心力衰竭临床试验提供了及时的机会.
- 利用这些技术可以提高试验实用性,减少延迟,并改善新治疗方法的证据基础.
- 这种方法对于快速推进心力衰竭管理中的护理策略至关重要.
相关概念视频
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Pulse rhythm
805
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
805
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
433
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
433


